|
⚲
|
| Keyboard |
| Ballantyne John
✚
|
|
|---|---|
| CIK # | 0001701346 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001701346] | |
| 4 | [0001701346] | |
| SC 13D | [0001701346] | |
| SC 13G | [0001701346] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Ballantyne John | Integrity Applications Inc | [2020-02-25] |
| Ballantyne John | Integrity Applications Inc | [2017-03-20] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ballantyne John | |
| Glucotrack Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Glucotrack Inc GCTK
Common Stock, par value $0.001 per share
|
2025-03-26 | Grant | 4,126 | $0.00 | |
|
Glucotrack Inc GCTK
Series B Common Warrant · derivative
|
2025-03-12 | Option exercise | 132,036 | $0.00 | |
|
Glucotrack Inc GCTK
Common Stock, par value $0.001 per share
|
2025-03-12 | Option exercise | 2,560,553 | $0.00 | |
|
Glucotrack Inc GCTK
Series B Common Warrant · derivative
|
2024-11-14 | Grant | 132,036 | ||
|
Glucotrack Inc GCTK
Common Stock, par value $0.001 per share
|
2024-11-14 | Other | 132,036 | $31.00 | 4,093,116 |
|
Glucotrack Inc GCTK
Series A Common Warrant · derivative
|
2024-11-14 | Grant | 132,036 | ||
|
Glucotrack Inc GCTK
Warrants to Purchase Common Stock · derivative
|
2024-07-30 | Buy | 59,260 | ||
|
Glucotrack Inc GCTK
Warrants to Purchase Common Stock · derivative
|
2024-07-30 | Buy | 76,191 | ||
|
Glucotrack Inc GCTK
Warrants to Purchase Common Stock · derivative
|
2024-07-30 | Buy | 106,667 |